It is an honor to announce the 6th World Congress on Targeting Phage & Antibiotic Resistance 2022 will be held on November 24-25, 2022.
Targeting Phage & Antibiotic Resistance 2022 is organized under the hospices of the International Society of Microbiota (ISM).
Biotech research for innovative techniques and novel strategies is greatly employed to combat the struggle against infectious diseases. However, the application of new creations does not always go as planned, hazardous consequences can emerge. The unknown consequences and underestimated risks can be dangerous. The discovery of phage therapy was a great achievement in terms of fighting the antibiotic resistance battle, but today, phage resistance has also emerged as an outcome of this creation.
Still, we cannot disregard the major advantages of this therapy. Currently, phage therapy has been proved successful in being a safer alternative for antibiotics, thanks to its narrow host range and its minimal damaging impact on human microbiota.
Also, today phage therapy has further evolved and its applications have surpassed the aim of fighting microbes. Engineered bacteriophages are being used for many biotechnological purposes.
In this year’s congress, academics and industrials will gather to discuss the most recent studies in phage therapy including its pros and cons. The major aim behind Targeting Phage & Antibiotic Resistance 2022 is to cover the aspects of phage therapy today, especially with the emergence of phage resistance. It will also shed light on the new bacteriophage-based innovations and discoveries.
Among the topics that will be discussed:
- Phage Therapy: Recent Advances & Challenges
- Bacteriophage Characterization & Isolation
- Antibacterial Activity & Phage Resistance
- Bacteriophages & Microbiota: On the Way to a Medical Revolution?
- Bacteriophage Prophylactic & Therapeutic Applications
- Engineered Bacteriophages: Innovations & Biotechnology
We hope that you will join us for this dynamic and strategic program and look forward to seeing you all.
On behalf of the scientific committee
Targeting Phage & Antibiotic Resistance 2022